73,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Apathy is described as a lack of motivation, loss of interest, and decreased initiative and has a negative outcomes for both the patient and the caregiver. This book provides a review of apathy in neurological and psychiatric disorders as well as a review of apathy definitions, apathy measurements, apathy research and apathy treatments.

Produktbeschreibung
Apathy is described as a lack of motivation, loss of interest, and decreased initiative and has a negative outcomes for both the patient and the caregiver. This book provides a review of apathy in neurological and psychiatric disorders as well as a review of apathy definitions, apathy measurements, apathy research and apathy treatments.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
André Aleman received his masters degree in Psychology (Neuropsychology and Psychophysiology) at Utrecht University in 1997, where he also obtained his PhD (cum laude), in 2001. His current research interests concern the neural underpinnings of cognitive and affective dysfunctions in psychosis and depression, in addition to changes in cognitive brain function during aging. In 2006 he received a European Young Investigator (EURYI) Award (1.2 M euro) from the European Science Foundation. In 2011 and 2012 he received large grants (1.5 M euro each) from the Netherlands Organization for Scientific Research (VICI) and the European Research Council (ERC Starting/consolidator grant). Dr. Krista Lanctôt is a Senior Scientist in the Hurvitz Brain Sciences Program at Sunnybrook Research Institute, the head of the Neuropsychopharmacology Research Group and the Executive Director of the Medical Outcomes and Research in Economics (MORE) Research Centre. She is a full professor in the Departments of Psychiatry and Pharmacology & Toxicology at the University of Toronto. She is the Vice Chair of Basic and Clinical Research in the Department of Psychiatry at University of Toronto. Dr. Lanctôt is an active researcher in clinical pharmacology and has published over 300 manuscripts. Her research focuses on optimizing the pharmacotherapy of cognition and neuropsychiatric symptoms associated with dementia and predementia states.